NIPH Clinical Trials Search

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied	Parkinson's disease
Date of first enrollment	18/09/2007
Target sample size
Countries of recruitment
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : SPM962 INN of investigational material : Therapeutic category code : 116 Antiperkinsonism agents Dosage and Administration for Investigational material : Transdermal

Outcome(s)

Primary Outcome	Efficacy/safety
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum	>= 30age old
Age maximum	<= 79age old
Gender	Both
Include criteria	1. Subject is diagnosed as having Parkinson's disease 2. Subject is 30 and over, and less than 80 years of age at the time of informed consent. 3. Subject is diagnosed as modified Hoehn & Yahr stage I - III. 4. Subject's total UPDRS Part II sum score and Part III sum score is 10 and over at screening test.
Exclude criteria